Approval · Notice of Compliance 521 · 2004
LEVULAN KERASTICK: Notice of Compliance 521
Issued April 5, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 521
- Date
- April 5, 2004
- Company
- Dusa Pharmaceuticals Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Photodynamic therapy photosensitizer
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LEVULAN KERASTICK | 02243933 | Marketed |